{"transactions":[{"id":768589,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-21T22:05:02.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2318,"price":50.2,"value":116363.6,"ownership":{"direct":true},"balance_after":42472,"source":{"system":"sec-edgar","filing":"0001628280-26-037455","document":"wk-form4_1779401100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026037455/wk-form4_1779401100.xml","form_type":"4"}},{"id":835673,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-03-18T17:42:15.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":36680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter."}],"balance_after":36680,"derivative":{"exercise_price":57.43,"exercise_date":"2027-03-16","expiration_date":"2036-03-15","underlying":"Common Stock","underlying_shares":36680},"source":{"system":"sec-edgar","filing":"0001628280-26-019269","document":"wk-form4_1773855732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019269/wk-form4_1773855732.xml","form_type":"4"}},{"id":835672,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T17:42:15.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1245,"price":56.05,"value":69782.25,"ownership":{"direct":true},"balance_after":44790,"source":{"system":"sec-edgar","filing":"0001628280-26-019269","document":"wk-form4_1773855732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019269/wk-form4_1773855732.xml","form_type":"4"}},{"id":835671,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T17:42:15.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":15410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 16, 2026. Price not applicable."}],"balance_after":46035,"source":{"system":"sec-edgar","filing":"0001628280-26-019269","document":"wk-form4_1773855732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019269/wk-form4_1773855732.xml","form_type":"4"}},{"id":905771,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-13T23:58:22.000Z","date":"2025-10-31","kind":"grant","planned":false,"acquired":true,"shares":80,"price":45.535,"value":3642.8,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on October 31, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":30625,"source":{"system":"sec-edgar","filing":"0001628280-26-008231","document":"wk-form5_1771027100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026008231/wk-form5_1771027100.xml","form_type":"5"}},{"id":1137828,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-22T21:02:57.000Z","date":"2025-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2155,"price":59.93,"value":129149.15,"ownership":{"direct":true},"balance_after":30545,"source":{"system":"sec-edgar","filing":"0001048477-25-000080","document":"wk-form4_1747947769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000080/wk-form4_1747947769.xml","form_type":"4"}},{"id":1157718,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-06T21:07:22.000Z","date":"2025-05-02","kind":"sale","planned":true,"acquired":false,"shares":273,"price":64.92,"value":17723.16,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Trade made pursuant to a 10b5-1 plan executed on September 13, 2024."}],"balance_after":32700,"source":{"system":"sec-edgar","filing":"0001048477-25-000053","document":"wk-form4_1746565636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000053/wk-form4_1746565636.xml","form_type":"4"}},{"id":1157717,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-06T21:07:22.000Z","date":"2025-04-30","kind":"grant","planned":true,"acquired":true,"shares":273,"price":54.137,"value":14779.401,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":32973,"source":{"system":"sec-edgar","filing":"0001048477-25-000053","document":"wk-form4_1746565636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000053/wk-form4_1746565636.xml","form_type":"4"}},{"id":1201346,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T22:25:52.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":30880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":30880,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":30880},"source":{"system":"sec-edgar","filing":"0001048477-25-000035","document":"wk-form4_1742336744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000035/wk-form4_1742336744.xml","form_type":"4"}},{"id":1201345,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:25:52.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":13310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":32700,"source":{"system":"sec-edgar","filing":"0001048477-25-000035","document":"wk-form4_1742336744.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000035/wk-form4_1742336744.xml","form_type":"4"}},{"id":1505948,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-05-22T20:36:23.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":33520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on May 20, 2025 and 1/48th on the 1st day of each month thereafter."}],"balance_after":33520,"derivative":{"exercise_price":77.05,"exercise_date":"2025-05-20","expiration_date":"2034-05-19","underlying":"Common Stock","underlying_shares":33520},"source":{"system":"sec-edgar","filing":"0001048477-24-000090","document":"wk-form4_1716410173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000090/wk-form4_1716410173.xml","form_type":"4"}},{"id":1505947,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-22T20:36:23.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":4700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2024. Price not applicable."}],"balance_after":19390,"source":{"system":"sec-edgar","filing":"0001048477-24-000090","document":"wk-form4_1716410173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000090/wk-form4_1716410173.xml","form_type":"4"}},{"id":1505946,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":45382,"kind":"person","name":"Hubbard Cristin","position":1,"cik":"0002021836","reported_name":"Hubbard Cristin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-22T20:36:23.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":14690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 20, 2024. Price not applicable."}],"balance_after":14690,"source":{"system":"sec-edgar","filing":"0001048477-24-000090","document":"wk-form4_1716410173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000090/wk-form4_1716410173.xml","form_type":"4"}}]}